Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

F-Actin-Uncapping Protein LRRC16A (CARMIL1) (AA 1321-1371) antibody

This anti- antibody is a Rabbit Polyclonal antibody detecting in IP and WB. Suitable for Human.
Catalog No. ABIN7450068

Quick Overview for F-Actin-Uncapping Protein LRRC16A (CARMIL1) (AA 1321-1371) antibody (ABIN7450068)

Target

F-Actin-Uncapping Protein LRRC16A (CARMIL1)

Reactivity

Human

Host

  • 4
Rabbit

Clonality

  • 4
Polyclonal

Conjugate

  • 1
  • 1
  • 1
  • 1
Un-conjugated

Application

Immunoprecipitation (IP), Western Blotting (WB)
  • Binding Specificity

    AA 1321-1371

    Purpose

    Rabbit anti-CARMIL Antibody, Affinity Purified

    Predicted Reactivity

    Mouse

    Purification

    Affinity Purified

    Immunogen

    Between AA 1321 and 1371

    Isotype

    IgG
  • Application Notes

    IP: 2 - 10 μg/mg lysate

    WB: 1:2,000 - 1:10,000

    Restrictions

    For Research Use only
  • Concentration

    1000 μg/mL

    Buffer

    Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Expiry Date

    12 months
  • Target

    F-Actin-Uncapping Protein LRRC16A (CARMIL1)

    Alternative Name

    CARMIL

    Background

    Background: CARMIL binds CAPZA2 with high affinity and significantly decreases CAPZA2 affinity for actin barbed ends. It increases the rate of elongation from seeds in the presence of CAPZA2, however, seems unable to nucleate filaments. CARMIL Rapidly uncaps barbed ends capped by CAPZA2 and enhances barbed-end actin polymerization (By similarity).CARMIL may control actin dynamics in lamellipodi and be required for cell migration [taken from the Universal Protein Resource (UniProt) Q5VZK9].

    Gene ID

    55604

    NCBI Accession

    NP_060110

    UniProt

    Q5VZK9
You are here:
Chat with us!